Pantec Biosolutions expands scientific advisory board
This article was originally published in Scrip
The Liechtenstein-based drug delivery company Pantec Biosolutions has expanded its scientific advisory board to include Professor Rox Anderson, Dr Jean-Luc Levy and Professor Robert Strohal. Dr Anderson is a professor at Harvard Medical School, an adjunct professor at Massachusetts Institute of Technology and director of the Wellman Center for Photomedicine at Massachusetts General Hospital; Dr Levy has more than 20 years' experience in the field of health technology, specifically for laser application in dermatology and cosmetology; and Dr Strohal is associate professor and head of the department of dermatology and venerology at the Federal University Teaching Hospital Feldkirch, Austria.
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.